|
| |
Bubonic PlagueDownload PDF containing detailed information.
Recent Publications on Bubonic Plague: |  |
Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic plague model and induces rapid protection against pneumonic plague.
An important virulence strategy evolved by bacterial pathogens to overcome... | 18th November, 2009
| Department of Biochemistry and Molecular Genetics, Israel Institute for
| PLoS One. 2009 Jun 16;4(6):e5938.
DOI Direct Link |
[Doctor Ricardo Davila Boza: pioneer of infectious disease specialists in Chile. Hygienist and public health expert]
Dr. Ricardo Davila Boza (1850 -1937) was a man whose personality had no... | 17th November, 2009
| Pontificia Universidad Catolica de Chile, Facultad de Medicina Programa de
| Rev Chilena Infectol. 2008 Dec;25(6):475-82. Epub 2009 Jan 29.
DOI Direct Link |
Plague.
Killed whole cell vaccines for plague were first produced as long ago as... | 20th October, 2009
| Defence Science and Technology Laboratory (DSTL), Porton Down, Salisbury,
| Vaccine. 2009 Nov 5;27 Suppl 4:D56-60.
DOI Direct Link |
Plague vaccines and the molecular basis of immunity against Yersinia pestis.
Yersinia pestis is the causative agent of bubonic and pneumonic plague,... | 30th September, 2009
| Department of Microbiology, University of Chicago, Chicago, IL, USA.
| Hum Vaccin. 2009 Dec 19;5(12).
|
Gr1+ cells control growth of YopM-negative yersinia pestis during systemic plague.
YopM, a protein toxin of Yersinia pestis, is necessary for virulence in a... | 4th September, 2009
| Department of Microbiology, Immunology, and Molecular Genetics, University
| Infect Immun. 2009 Sep;77(9):3791-806. Epub 2009 Jul 6.
DOI Direct Link |
→View more research publications. |
Press Releases About Bubonic Plague:
|
 |
| NanoLogix Begins Construction of Production Facility for Medical Test Kits |
21st April, 2009 |
NanoLogix, Inc. |
HUBBARD, Ohio, April 21 /PRNewswire-FirstCall/ -- NanoLogix, Inc. (OTC: NNLX) -- NanoLogix Inc. has begun construction on a 2,800 square foot manufacturing facility at its headquarters in Hubbard,
|
| New Weapon in BioDefense Research: NanoLogix Kit Speeds Rapid Diagnostics of Anthrax and Bubonic Plague |
13th April, 2009 |
NanoLogix, Inc. |
HUBBARD, Ohio, April 13 /PRNewswire-FirstCall/ -- NanoLogix, Inc. (OTC: NNLX) a biotechnology company, is pleased to provide the following information:
An independent study has found that
|
BioPortfolio Ltd. offers e-mail and postal lists for Bubonic Plague scientists - we have details of around 28 individuals working on Bubonic Plague .
This page has been viewed 738 times
Recent Search Terms used to find this page: bubonic plague in chicago | bubonic plague 2009 | bubonic plague 2009 | bubonic plague 2009 | bubonic plague pathogen | spatial distribution of bubonic plague | bubonic plague 2009 | bubonic toxin | description of bubonic plague pathogen | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Bubonic Plague across BioPortfolio, or for Bubonic Plague Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
